These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4152327)

  • 21. [Long-term postoperative course and surgical indications in patients with hypertrophic obstructive cardiomyopathy].
    Gobet DA; Rothlin ME
    Schweiz Med Wochenschr; 1984 Mar; 114(13):436-48. PubMed ID: 6538990
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical features of idiopathic hypertrophic cardiomyopathy.
    Toshima H; Fukami T
    Jpn Circ J; 1971 Jul; 35(7):777-83. PubMed ID: 5170993
    [No Abstract]   [Full Text] [Related]  

  • 23. Prosthetic heart valve replacement. Causes of early postoperative death.
    Colapinto ND; Silver MD
    J Thorac Cardiovasc Surg; 1971 Jun; 61(6):938-44. PubMed ID: 5104325
    [No Abstract]   [Full Text] [Related]  

  • 24. [The retrospective study of sudden cardiac death in 118 cases].
    He K; Xu JS; Wang ZY
    Fa Yi Xue Za Zhi; 2007 Aug; 23(4):299-301. PubMed ID: 17896526
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Primary echinococcosis of the myocardium].
    Ciampi Roti A
    Arch De Vecchi Anat Patol; 1979 Mar; 63(3):435-80. PubMed ID: 162435
    [No Abstract]   [Full Text] [Related]  

  • 26. [Epidemiological and clinical observations on 300 cases of primary myocardiopathy].
    Vajola SF; Lax AM; Castellari M; Ceci V; Masini V
    G Ital Cardiol; 1979; 9(4):434-7. PubMed ID: 456805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Problems posed by anesthesia and intensive care in obstructive cardiomyopathy].
    Vigreux JM; Dhote J; Passelecq J; Dubost C
    Anesth Analg (Paris); 1978; 35(6):1001-8. PubMed ID: 754551
    [No Abstract]   [Full Text] [Related]  

  • 28. [Supraventricular tachycardia in obstructive myocardiopathy. A retrospective study of 51 cases by the Working Group on myocardiography].
    Bouhour JB; Bory M; Bourmayan C; Chiffoleau S; Favereau X; Foussard C; Komajda M; Lassabe G; Morand P; Neimann JL
    Arch Mal Coeur Vaiss; 1981 Sep; 74(9):993-1000. PubMed ID: 6794523
    [No Abstract]   [Full Text] [Related]  

  • 29. Patient selection and results of cardiac transplantation in patients with cardiomyopathy.
    Thompson ME; Kormos RL; Zerbe A; Hardesty RL
    Transplant Proc; 1988 Feb; 20(1 Suppl 1):782-5. PubMed ID: 3279668
    [No Abstract]   [Full Text] [Related]  

  • 30. [Proceedings: Prevention of myocardial degeneration in a disease model of hereditary cardiomyopathy].
    Lossnitzer K; Konrad A; Heine HW; Ziegler E; Stauch M
    Z Kardiol; 1975; Suppl 2():39. PubMed ID: 128239
    [No Abstract]   [Full Text] [Related]  

  • 31. Noncompaction of the ventricular myocardium.
    Weiford BC; Subbarao VD; Mulhern KM
    Circulation; 2004 Jun; 109(24):2965-71. PubMed ID: 15210614
    [No Abstract]   [Full Text] [Related]  

  • 32. Clinical pathways of cardiomyopathy.
    Stapleton JF; Segal JP; Harvey WP
    Circ Res; 1974 Aug; 35(2):suppl II:168-78. PubMed ID: 4276498
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial bridging, a frequent component of the hypertrophic cardiomyopathy phenotype, lacks systematic association with sudden cardiac death.
    Basso C; Thiene G; Mackey-Bojack S; Frigo AC; Corrado D; Maron BJ
    Eur Heart J; 2009 Jul; 30(13):1627-34. PubMed ID: 19406869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factors interfering with the survival of patients with permanent artificial pacemakers].
    Sant'Anna JR; Lucchese FA; Kalil RA; Prates PR; Pereira E; Tavares CE; Nesralla IA
    Arq Bras Cardiol; 1984 May; 42(5):331-7. PubMed ID: 6508590
    [No Abstract]   [Full Text] [Related]  

  • 35. [Use of beta-receptor blockaders in hypertrophic obstructive cardiomyopathy (HOCM)].
    Kuhn H; Loogen F
    Internist (Berl); 1978 Sep; 19(9):527-31. PubMed ID: 29851
    [No Abstract]   [Full Text] [Related]  

  • 36. Follow-up observations and prognosis in primary myocardial disease.
    Shugoll GI; Bowen PJ; Moore JP; Lenkin ML
    Arch Intern Med; 1972 Jan; 129(1):67-72. PubMed ID: 4257509
    [No Abstract]   [Full Text] [Related]  

  • 37. Hypertrophic obstructive cardiomyopathy in an infant--propranolol therapy for three years.
    Shand DG; Sell CG; Oates JA
    N Engl J Med; 1971 Oct; 285(15):843-4. PubMed ID: 4255121
    [No Abstract]   [Full Text] [Related]  

  • 38. [Determinants of immediate postoperative risk in the implantation of permanent artificial cardiac pacemakers].
    Sant'Anna JR; Lucchese FA; Kalil RA; Prates PR; Pereira EM; Nesralla IA
    Arq Bras Cardiol; 1984 Feb; 42(2):117-21. PubMed ID: 6477178
    [No Abstract]   [Full Text] [Related]  

  • 39. Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity. A report of 80 cases.
    Tabib A; Miras A; Taniere P; Loire R
    Eur Heart J; 1999 Jun; 20(12):900-3. PubMed ID: 10329096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Proceedings: Hypertrophic obstructive cardiomyopathy].
    Loogen F; Krelhaus W; Kuhn H
    Z Kardiol; 1975; Suppl 2():3. PubMed ID: 128237
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.